Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes B VAN Rees

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Interventions|August 20, 2018
Difficult Vascular Access in Urgent Coronary Artery Angiogram: A Rare Case of a Persistent Sciatic ArteryJohannes B van Rees, Jose M Montero-Cabezas, Eidrees Ghariq, et al.
Expert Review of Cardiovascular Therapy|November 30, 2012
Primary prevention implantable cardioverter-defibrillator treatment: how to identify patients most likely to benefit?Joep Thijssen, Johannes B van Rees, Martin J Schalij, et al.
Journal of the American College of Cardiology|August 27, 2011
Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trialsJohannes B van Rees, Mihály K de Bie, Joep Thijssen, et al.
Current Medical Research and Opinion|May 13, 2011
How to reduce the incidence of contrast induced acute kidney injury after cardiac invasive procedures, a review and practical recommendationsMihály K de Bie, Johannes B van Rees, Charles A Herzog, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2011
Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-lifeGuido H Van Welsenes, Johannes B Van Rees, Joep Thijssen, et al.
Heart (British Cardiac Society)|May 25, 2013
Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practiceMihály K de Bie, Joep Thijssen, Johannes B van Rees, et al.
Journal of the American College of Cardiology|January 29, 2011
Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortalityJohannes B van Rees, C Jan Willem Borleffs, Mihály K de Bie, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 7, 2011
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patientsGuido H van Welsenes, Johannes B van Rees, C Jan Willem Borleffs, et al.
Pacing and Clinical Electrophysiology : PACE|December 4, 2009
Implementation of lead safety recommendationsJohannes B VAN Rees, C Jan Willem Borleffs, Jeroen J Bax, et al.
Journal of the American College of Cardiology|February 27, 2010
Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patientsC Jan Willem Borleffs, Johannes B van Rees, Guido H van Welsenes, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Interventions|August 20, 2018
Difficult Vascular Access in Urgent Coronary Artery Angiogram: A Rare Case of a Persistent Sciatic ArteryJohannes B van Rees, Jose M Montero-Cabezas, Eidrees Ghariq, et al.
Expert Review of Cardiovascular Therapy|November 30, 2012
Primary prevention implantable cardioverter-defibrillator treatment: how to identify patients most likely to benefit?Joep Thijssen, Johannes B van Rees, Martin J Schalij, et al.
Journal of the American College of Cardiology|August 27, 2011
Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trialsJohannes B van Rees, Mihály K de Bie, Joep Thijssen, et al.
Current Medical Research and Opinion|May 13, 2011
How to reduce the incidence of contrast induced acute kidney injury after cardiac invasive procedures, a review and practical recommendationsMihály K de Bie, Johannes B van Rees, Charles A Herzog, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2011
Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-lifeGuido H Van Welsenes, Johannes B Van Rees, Joep Thijssen, et al.
Heart (British Cardiac Society)|May 25, 2013
Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practiceMihály K de Bie, Joep Thijssen, Johannes B van Rees, et al.
Journal of the American College of Cardiology|January 29, 2011
Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortalityJohannes B van Rees, C Jan Willem Borleffs, Mihály K de Bie, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 7, 2011
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patientsGuido H van Welsenes, Johannes B van Rees, C Jan Willem Borleffs, et al.
Pacing and Clinical Electrophysiology : PACE|December 4, 2009
Implementation of lead safety recommendationsJohannes B VAN Rees, C Jan Willem Borleffs, Jeroen J Bax, et al.
Journal of the American College of Cardiology|February 27, 2010
Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patientsC Jan Willem Borleffs, Johannes B van Rees, Guido H van Welsenes, et al.
Pageof 4